Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)
Statin Modulation of Monocyte/Macrophage Activation for HAND Treatment
Sponsor: University of Pennsylvania
This PHASE4 trial investigates HIV Dementia and is currently completed. University of Pennsylvania leads this study, which shows 14 recorded versions since 2013 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Dec 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 9 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE4
-
Dec 2019 — Dec 2020 [monthly]
Completed PHASE4
-
Jun 2019 — Dec 2019 [monthly]
Completed PHASE4
-
May 2019 — Jun 2019 [monthly]
Completed PHASE4
-
Jun 2018 — May 2019 [monthly]
Completed PHASE4
-
Dec 2017 — Jun 2018 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Feb 2017 — Dec 2017 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .